Clinical Trial Update: Safety and Tolerability Evaluation of CEL001 Injection in Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and tolerability of CEL001 Injection in patients with advanced solid tumors; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• CEL001 Injection (CEL001)

Snippet

Sponsor: Guangzhou Xiling Biotechnology Co., Ltd. | Conditions: Advanced Solid Tumors (Phase 1) | Phase 1 | Status: RECRUITING